Amylyx Pharmaceuticals, Inc.
USD13.20
-0.09 (-0.68%)
CEO
Joshua Cohen
IPO Date
2022-01-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$13.30
Prev. Close
$13.29
Day Low
$13.07
Day High
$13.53
52W Low
$4.76
52W High
$18.61
Market Cap
$1.10B
Volume
0.99M
| 248,865 |
| $0.00 |
| 9 Mar 2026 | Cohen Joshua B | director, officer: Co-Chief Executive Officer | A-Award | Acquired | 373,295 | $14.10 |
| 9 Mar 2026 | Mazzariello Gina | Chief Legal Officer | A-Award | Acquired | 74,660 | $0.00 |
| 9 Mar 2026 | Mazzariello Gina | Chief Legal Officer | A-Award | Acquired | 111,990 | $14.10 |
| 9 Mar 2026 | FRATES JAMES M | Chief Financial Officer | A-Award | Acquired | 95,990 | $0.00 |
| 9 Mar 2026 | FRATES JAMES M | Chief Financial Officer | A-Award | Acquired | 143,985 | $14.10 |
| 9 Mar 2026 | Klee Justin B. | director, officer: Co-Chief Executive Officer | A-Award | Acquired | 248,865 | $0.00 |
| 9 Mar 2026 | Klee Justin B. | director, officer: Co-Chief Executive Officer | A-Award | Acquired | 373,295 | $14.10 |
| 9 Mar 2026 | Bedrosian Camille L | Chief Medical Officer | A-Award | Acquired | 95,990 | $0.00 |